The artificial urinary sphincter (AUS) remains the 00 gold standard 00 for the treatment of post prostatectomy stress urinary incontinence (PPSUI). However, in recent years, minimally invasive, less expensive sling device (AdVance) are offered as potential alternative treatments. We sought to investigate the long-term cost-utility of the AUS compared with Transobturator Retroluminal Repositioning Sling (AdVance) in the treatment of severe PPSUI.
INTRODUCTION AND OBJECTIVES:
The artificial urinary sphincter (AUS) remains the 00 gold standard 00 for the treatment of post prostatectomy stress urinary incontinence (PPSUI). However, in recent years, minimally invasive, less expensive sling device (AdVance) are offered as potential alternative treatments. We sought to investigate the long-term cost-utility of the AUS compared with Transobturator Retroluminal Repositioning Sling (AdVance) in the treatment of severe PPSUI.
METHODS: A Markov model with Monte-Carlo simulation was developed to estimate the incremental cost-effectiveness ratio (ICER) of AUS vs. AdVance sling from a provincial payer perspective over a 10-year period. Probability estimates, success rates, healthcare resources and utilities were obtained from published literature when available or by expert opinion. Cost data included in this model were obtained from provincial health care insurance system and hospital data in 2016-Canadian Dollars.
RESULTS: AUS Implantation had a 10-year mean total cost of $12299 (SDAE3509) for 8.53 quality-adjusted life years (QALYs). On the other hand, AdVance sling had a mean total cost of $20675 (SDAE12435) for 7.98 QALYs. The cost-utility analysis over a 10-year period showed that AUS becomes cost-effective when compared to AdVance sling starting the 4th year in the treatment period. The incremental cost savings of AUS over 10-year period was $8376 with an added effectiveness of 0.55 QALYs. Consequently, the AUS implementation is the dominant strategy over the AdVance sling over a 5-and 10-year time-horizon. CONCLUSIONS: Although the initial cost of sling is attractive, superior long-term outcomes are demonstrated with durable high success rate of AUS in men with severe PPSUI. Hence, the AUS implementation strategy over a 10-year period time is estimated to be more economical to our health care system. More studies are needed to define utility values for health states experienced by males with PPSUI. This will enhance our ability to develop more accurate cost-utility models. The majority of health care cost data are based on charges or reimbursements, but these approaches fail to accurately represent the money hospitals actually spend to provide services. Time-driven activity-based costing (TDABC) provides a methodology to better understand true costs of providing a health care service and the variations in cost based on variance in timing. We applied TDABC analysis to a percutaneous nephrolithotomy (PCNL) care pathway.
METHODS: The care pathway for PCNL was defined as the time from patient arrival to the preoperative area to discharge from post anesthesia care unit (PACU) to the hospital floor. Process maps were created with perioperative stakeholders to define the activities involved in PCNL. Stop-watch timing was performed for eleven PCNL cases. The cost rate for attending urologists was calculated using publicly available salaries and estimated capacity, additional cost rates were estimated using a ratio of the averaged salaries for each staff position.
RESULTS: The activities demonstrating the greatest time variance were PACU recovery, preoperative holding, and stone clearance (214AE100.3, 99AE67.2 and 36AE28.2 minutes respectively). The activities with the least variation were anesthesia extubation, nephrostomy tube placement and patient repositioning (13AE3.9, 9AE4.3, 16AE6.3 minutes respectively). Total cost including disposables and overhead for the average PCNL was $5319. Preoperative care accounted for $470 (7%), intraoperative care accounted for $4351 (84%) and post-operative care accounted for $353 (9%) of the total. Thirty-seven percent of cost was attributable to disposables. Theoretical modeling with an attending performing all perioperative activities (rather than a resident) increased the human resource cost by 31%. Removing the highest time outliers from each activity reduced the cost by 21%.
CONCLUSIONS: Although utilizing the operative room is the most cost intensive activity for PCNL, variation exists during different phases of care. Opportunities for standardization to reduce cost is greatest in the pre-and post-operative areas. The TDABC methodology allows for estimation of true costs for PCNL and modeling of care pathway variation in order to understand health care costs and target areas for increased care value. METHODS: A dedicated ERAS protocol was implemented in our department in July 2015. The subsequent year all consecutive patients were treated according to this protocol (ERAS group). They e414 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 
